A therapeutic piperacillin and meropenem serum concentration
monitoring reveals suboptimal pharmacodynamic (PD) response in
standard therapeutic regimes

Skip to top bar Skip to header Skip to content Skip to footer

Publications Detailed Information on Publication Record

Detailed Information on Publication Record

a 2024

A therapeutic piperacillin and meropenem serum concentration monitoring reveals suboptimal pharmacodynamic (PD) response in standard therapeutic regimes

ŠŤASTNÁ, Nela and Eliška MARACZEK MARKOVÁ

Basic information

Original name

A therapeutic piperacillin and meropenem serum concentration monitoring reveals suboptimal pharmacodynamic (PD) response in standard therapeutic regimes

Authors

ŠŤASTNÁ, Nela and Eliška MARACZEK MARKOVÁ

Edition

47th European Cystic Fibrosis Conference, 2024

Other information

Type of outcome

Konferenční abstrakt

Confidentiality degree

není předmětem státního či obchodního tajemství

Změněno: 9/7/2024 00:55, MUDr. Nela Šťastná

ŠŤASTNÁ, Nela and Eliška MARACZEK MARKOVÁ. A therapeutic piperacillin and meropenem serum concentration monitoring reveals suboptimal pharmacodynamic (PD) response in standard therapeutic regimes. In 47th European Cystic Fibrosis Conference. 2024.

@proceedings{2417597,
   author = {Šťastná, Nela and Maraczek Marková, Eliška},
   booktitle = {47th European Cystic Fibrosis Conference},
   title = {A therapeutic piperacillin and meropenem serum concentration monitoring reveals suboptimal pharmacodynamic (PD) response in standard therapeutic regimes},
   year = {2024}
}

TY  - CONF
ID  - 2417597
AU  - Šťastná, Nela - Maraczek Marková, Eliška
PY  - 2024
TI  - A therapeutic piperacillin and meropenem serum concentration monitoring reveals suboptimal pharmacodynamic (PD) response in standard therapeutic regimes
ER  -